Recorded on site at the ASGCT 2026 Annual Meeting in Boston, this mini-series introduces listeners to ASGCT members and the work driving progress across the cell and gene therapy field. In each episode, members are invited to share their backgrounds, discuss the current state of the field, and reflect on the value of ASGCT membership. This series of brief, engaging conversations will help listeners get to know the people, perspectives, and ideas shaping the ASGCT community.
In this episode, host Ben McLeod of the ASGCT Communications Committee talks with Dr. Mark Deehan of MassGeneral Hospital. Dr. Deehan discusses being a new member of ASGCT and how receiving an ASGCT Career Development Award, funded by the Foundation for Angelman Syndrome Therapeutics (FAST), has advanced his lab work.
Music: 'Origami' by Scott Buckley - released under CC-BY 4.0. www.scottbuckley.com.au

Development of a secretable frataxin for Friedrich’s ataxia with Dr. Dan DuBreuil
19:48

Member Minutes: Chrissy Green
11:20

A CFTR mRNA isoform for the treatment of 3’ CFTR PTC variants with Normand Allaire
40:23